re: C9orf72 gene
EnClear, Developer of Device to Slow ALS, Spins Out of QurAlis
EnClear, Developer of Device to Slow ALS, Spins Out of QurAlis

re: Pseudobulbar affect
Assessment of use of combined dextromethorphan and quinidine in patients with dementia or Parkinson disease after US Food and Drug Administration approval for pseudobulbar affect
Combined dextromethorphan + quinidine in dementia or PD Patients | JAMA | MDLinx

re: Glialblastoma
MediciNova Announces Initiation of Enrollment in a Clinical Trial of MN-166 (ibudilast) in Glioblastoma
MediciNova Announces Initiation of Enrollment in a Clinical Trial of MN-166 (ibudilast) in Glioblastoma

Molecular approaches to treatment under current investigation